Intravenous lidocaine: effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma--a report of a series

Anesth Analg. 1997 Oct;85(4):794-6. doi: 10.1097/00000539-199710000-00014.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Child
  • Child, Preschool
  • Female
  • Gangliosides / immunology*
  • Humans
  • Infusions, Intravenous
  • Lidocaine / administration & dosage
  • Lidocaine / therapeutic use*
  • Male
  • Neuroblastoma / therapy*
  • Pain / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Gangliosides
  • ganglioside, GD2
  • Lidocaine